• Bazedoxifene: Decoding SERM Tissue Selectivity in Osteoporos

  2026-06-27

  Explore Bazedoxifene, a third-generation selective estrogen receptor modulator, and its unique mechanistic basis for tissue-specific action in osteoporosis treatment research. This article delivers an in-depth scientific analysis of SERM selectivity, protocol implications, and assay design.

• Structural Insights into Bestatin Inhibition of Leucine Amin

  2026-06-26

  This pivotal study elucidates the three-dimensional structure of bovine lens leucine aminopeptidase (LAP) and details its inhibition by bestatin (Ubenimex) using high-resolution X-ray crystallography. The findings offer a mechanistic model for enzyme-catalyzed peptide hydrolysis and inform future experimental strategies in aminopeptidase research.

• Optimizing mRNA Delivery with EZ Cap™ Cy5 EGFP mRNA (5-moUTP

  2026-06-26

  EZ Cap™ Cy5 EGFP mRNA (5-moUTP) empowers researchers to precisely track mRNA delivery and protein expression in real time, thanks to its dual-fluorescent labeling and immune-evasive design. This article details advanced workflows, troubleshooting strategies, and key innovations that set this APExBIO product apart for quantitative transfection and functional genomics studies.

• Berberine Hydrochloride: Bridging Metabolic and Inflammatory

  2026-06-25

  This thought-leadership article explores how Berberine Hydrochloride, a natural AMPK activator supplied by APExBIO, enables translational researchers to dissect the molecular nexus between metabolic regulation and inflammation. Drawing on the latest findings in acute kidney injury (AKI) and inflammasome biology, the discussion situates Berberine Hydrochloride as a versatile tool for metabolic disease, diabetes and obesity models, and lipid metabolism research, while offering pragmatic guidance and a forward-looking translational outlook.

• Levofloxacin: Synthetic Fluoroquinolone Antibiotic in Advanc

  2026-06-25

  Levofloxacin empowers research far beyond antibacterial testing, enabling nuanced study of bacterial resistance mechanisms and bone cell modulation. This guide delivers actionable protocols, advanced troubleshooting, and strategic insights for maximizing assay success with this synthetic fluoroquinolone antibiotic.

• Glycosylation at Asn18 Is Essential for Ceramide Synthase 6

  2026-06-24

  This study demonstrates that glycosylation at asparagine-18 is critical for ceramide synthase 6 (CerS6) enzymatic activity, but does not influence the ER stress response. The work provides mechanistic insight into posttranslational regulation of sphingolipid biosynthesis and its downstream signaling effects, informing future experimental design in lipidomics and cell signaling research.

• Purmorphamine: Smoothened Agonist Workflows for Regenerative

  2026-06-23

  Purmorphamine stands out as a Smoothened agonist, delivering robust Hedgehog pathway activation for bone and sensory research. With precise dosing and workflow optimization, it enables reproducible osteoblast differentiation and innovative studies in both vertebrate and invertebrate systems.

• Trichostatin A (TSA): Protocols and Troubleshooting for Epig

  2026-06-23

  Trichostatin A (TSA) uniquely enables precise, reproducible HDAC inhibition and cell cycle arrest, making it a gold-standard tool for dissecting epigenetic regulation in cancer models. This guide delivers stepwise protocols, troubleshooting strategies, and translational insights that help researchers maximize the utility of TSA in both cell-based and in vivo studies.

• Pharmacokinetics of Corydalis Alkaloids in MASH Mouse Models

  2026-06-22

  This study systematically examines how metabolic dysfunction-associated steatohepatitis (MASH) alters the pharmacokinetics and tissue distribution of major Corydalis saxicola Bunting alkaloids in mice. Findings reveal that disease-induced changes in hepatic enzymes and transporters significantly impact systemic and liver exposures, informing more rational dosing strategies for MASLD/MASH research.

• Alternariol in Mycotoxin Research: Protocols and Innovations

  2026-06-22

  Alternariol (AOH) is emerging as a gold-standard probe for dissecting mycotoxin-driven liver fibrosis and apoptosis in cellular and enzymatic workflows. This guide delivers actionable protocols, optimization strategies, and key insights from omics-driven studies, advancing reproducibility and real-world relevance in toxicology research.

• H-Aggregated IR-1061 NIR-II Dye Enables Enhanced Tumor PTT

  2026-06-21

  Yu et al. present a lipid-peptide nanosystem leveraging H-aggregated IR-1061 for synergistic photothermal and chemotherapeutic cancer therapy. Their approach enables efficient in vivo tumor targeting, deep-tissue NIR-II imaging, and improved photothermal conversion, offering a new paradigm for molecular imaging and therapy integration.

• Phosphatase Inhibitor Cocktail 1: Enabling Signal Fidelity i

  2026-06-20

  Explore how Phosphatase Inhibitor Cocktail 1 preserves protein phosphorylation in cardiac research. This article uniquely connects inhibitor use to mechanistic insights from recent autophagy and hypertrophy studies, guiding advanced assay design.

• 3-hydroxybutyrate (BHBA) for Reliable Cell-Based Assays

  2026-06-19

  This article guides biomedical researchers through practical lab scenarios where 3-hydroxybutyrate (BHBA, SKU M1297) addresses challenges in cell viability, metabolic modeling, and pathway interrogation. Evidence-based recommendations and protocol insights illustrate why this APExBIO compound is a trusted choice for reproducibility and mechanistic rigor.

• Aurora A Kinase Regulates Trained Immunity via SAM Metabolis

  2026-06-19

  Li et al. (2025) reveal Aurora kinase A as a crucial regulator of trained immunity through modulation of endogenous S-adenosylmethionine (SAM) metabolism. Their findings uncover mechanistic links between Aurora A activity, metabolic-epigenetic crosstalk, and inflammatory gene priming, with significant implications for cancer biology and immunometabolic research.

• TAK1 Stabilization of YAP Drives Gastric Cancer Stem Cell Re

  2026-06-18

  This study reveals that TGFβ-activated kinase 1 (TAK1) stabilizes yes-associated protein (YAP), promoting self-renewal and oncogenesis in gastric cancer stem cells (GCSCs). The findings illuminate a critical pathway in gastric cancer progression and suggest new molecular targets for overcoming chemoresistance.

448 records 13/30 page Previous Next First page 上5页 1112131415 下5页 Last page